Patents by Inventor Peter Brouckaert

Peter Brouckaert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating cancer by combination therapy using TNF and alpha-galactosylceramide
    Patent number: 7959907
    Abstract: The invention relates to the treatment of cancer. More specifically the invention shows that the anti-cancer activity in mammals can be augmented by administering to the mammalian host a combination of a synergistically effective amount of TNF and alfa-galactosylceramide.
    Type: Grant
    Filed: February 20, 2008
    Date of Patent: June 14, 2011
    Assignees: VIB VZW, Universiteit Gent
    Inventors: Peter Brouckaert, Dirk Elewaut, Leander Huyghe
  • COMBINATION THERAPY USING TNF AND ALFA-GALACTOSYL CERAMIDE
    Publication number: 20100166697
    Abstract: The invention relates to the treatment of cancer. More specifically the invention shows that the anti-cancer activity in mammals can be augmented by administering to the mammalian host a combination of a synergistically effective amount of TNF and alfa-galactosylceramide.
    Type: Application
    Filed: February 20, 2008
    Publication date: July 1, 2010
    Inventors: Peter Brouckaert, Dirk Elewaut, Leander Huyghe